loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

List of Certificates of Suitability (CEPs) for r0_cep_2017_301___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 CENTRIENT PHARMACEUTICALS NETHERLANDS B.V. Delft NL (1)

filter

01 Cefprozil monohydrate, Powder and compacted (1)

filter

01 Netherlands (1)

filter

01 Withdrawn by Holder (1)

CENTRIENT PHARMACEUTICALS NETHERLAN...

Contact Supplier
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2017-301 - Rev 00
Withdrawn by Holder
Chemical
2019-06-06
2023-03-01
2342
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for R0-CEP 2017-301 - Rev 00 of Centrient Pharmaceuticals Netherlands B.v. Delft Nl

Looking for Certificates of Suitability (CEPs) for R0-CEP 2017-301 - Rev 00 of Centrient Pharmaceuticals Netherlands B.v. Delft Nl 1

20

Centrient Pharmaceuticals Netherlands B.v. Delft Nl, based in Gabon, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their significant offerings is Cefprozil monohydrate, Powder and compacted, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2017-301 - Rev 00

This Chemical Type CEP, issued on June 06, 2019, remains in force until March 01, 2023, ensuring its reliability within the pharmaceutical industry.

Substance Number 2342 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY